Report cover image

Global Ophthalmology Drugs Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18750333

Description

Global Ophthalmology Drugs Databank Market Report


The Ophthalmology Drugs market was valued at $37,185.8 Million in 2022, and is projected to reach $65,242.2 Million by 2031 growing at a CAGR of 6.49% from 2023 to 2031. Anti-VEGF Agents segment is expected to be the highest contributor to this market, with $14,005.3 Million in 2022, and is anticipated to reach $23,509.4 Million by 2031, registering a CAGR of 5.97%. Antiallergy segment is anticipated to reach $6,170.6 Million by 2031 with the highest CAGR of 8.27%. Anti-VEGF Agents and Anti-glaucoma segments collectively expected to account for about 57.9% share of the Ophthalmology Drugs market in 2022, with the former constituting around 37.7% share. Antiallergy and Anti-glaucoma segments are expected to witness significant growth rates at a CAGR of 8.27% and 7.00% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 28.4% in the overall Ophthalmology Drugs market in 2022, and is anticipated to reach 30.6% by 2031.

Table of Contents

100 Pages
1. Global Ophthalmology Drugs Market, By Drug Class
1.1. Overview
1.2. Antiallergy
1.2.1 Antiallergy Market, By Region
1.2.1.1 North America Antiallergy Market, By Country
1.2.1.2 Europe Antiallergy Market, By Country
1.2.1.3 Asia-Pacific Antiallergy Market, By Country
1.2.1.4 Rest of World Antiallergy Market, By Country
1.3. Anti-inflammatory
1.3.1 Anti-inflammatory Market, By Region
1.3.1.1 North America Anti-inflammatory Market, By Country
1.3.1.2 Europe Anti-inflammatory Market, By Country
1.3.1.3 Asia-Pacific Anti-inflammatory Market, By Country
1.3.1.4 Rest of World Anti-inflammatory Market, By Country
1.4. Anti-VEGF Agents
1.4.1 Anti-VEGF Agents Market, By Region
1.4.1.1 North America Anti-VEGF Agents Market, By Country
1.4.1.2 Europe Anti-VEGF Agents Market, By Country
1.4.1.3 Asia-Pacific Anti-VEGF Agents Market, By Country
1.4.1.4 Rest of World Anti-VEGF Agents Market, By Country
1.5. Anti-glaucoma
1.5.1 Anti-glaucoma Market, By Region
1.5.1.1 North America Anti-glaucoma Market, By Country
1.5.1.2 Europe Anti-glaucoma Market, By Country
1.5.1.3 Asia-Pacific Anti-glaucoma Market, By Country
1.5.1.4 Rest of World Anti-glaucoma Market, By Country
1.6. Other Drug Classes
1.6.1 Other Drug Classes Market, By Region
1.6.1.1 North America Other Drug Classes Market, By Country
1.6.1.2 Europe Other Drug Classes Market, By Country
1.6.1.3 Asia-Pacific Other Drug Classes Market, By Country
1.6.1.4 Rest of World Other Drug Classes Market, By Country
2. Global Ophthalmology Drugs Market, By Disease
2.1. Overview
2.2. Dry Eye
2.2.1 Dry Eye Market, By Region
2.2.1.1 North America Dry Eye Market, By Country
2.2.1.2 Europe Dry Eye Market, By Country
2.2.1.3 Asia-Pacific Dry Eye Market, By Country
2.2.1.4 Rest of World Dry Eye Market, By Country
2.3. Eye Allergy
2.3.1 Eye Allergy Market, By Region
2.3.1.1 North America Eye Allergy Market, By Country
2.3.1.2 Europe Eye Allergy Market, By Country
2.3.1.3 Asia-Pacific Eye Allergy Market, By Country
2.3.1.4 Rest of World Eye Allergy Market, By Country
2.4. Glaucoma
2.4.1 Glaucoma Market, By Region
2.4.1.1 North America Glaucoma Market, By Country
2.4.1.2 Europe Glaucoma Market, By Country
2.4.1.3 Asia-Pacific Glaucoma Market, By Country
2.4.1.4 Rest of World Glaucoma Market, By Country
2.5. Eye Infection
2.5.1 Eye Infection Market, By Region
2.5.1.1 North America Eye Infection Market, By Country
2.5.1.2 Europe Eye Infection Market, By Country
2.5.1.3 Asia-Pacific Eye Infection Market, By Country
2.5.1.4 Rest of World Eye Infection Market, By Country
2.6. Retinal Disorders
2.6.1 Retinal Disorders Market, By Region
2.6.1.1 North America Retinal Disorders Market, By Country
2.6.1.2 Europe Retinal Disorders Market, By Country
2.6.1.3 Asia-Pacific Retinal Disorders Market, By Country
2.6.1.4 Rest of World Retinal Disorders Market, By Country
2.7. Other Diseases
2.7.1 Other Diseases Market, By Region
2.7.1.1 North America Other Diseases Market, By Country
2.7.1.2 Europe Other Diseases Market, By Country
2.7.1.3 Asia-Pacific Other Diseases Market, By Country
2.7.1.4 Rest of World Other Diseases Market, By Country
3. Global Ophthalmology Drugs Market, By Dosage Form
3.1. Overview
3.2. Gels
3.2.1 Gels Market, By Region
3.2.1.1 North America Gels Market, By Country
3.2.1.2 Europe Gels Market, By Country
3.2.1.3 Asia-Pacific Gels Market, By Country
3.2.1.4 Rest of World Gels Market, By Country
3.3. Eye Solutions & Suspensions
3.3.1 Eye Solutions & Suspensions Market, By Region
3.3.1.1 North America Eye Solutions & Suspensions Market, By Country
3.3.1.2 Europe Eye Solutions & Suspensions Market, By Country
3.3.1.3 Asia-Pacific Eye Solutions & Suspensions Market, By Country
3.3.1.4 Rest of World Eye Solutions & Suspensions Market, By Country
3.4. Capsules and Tablets
3.4.1 Capsules and Tablets Market, By Region
3.4.1.1 North America Capsules and Tablets Market, By Country
3.4.1.2 Europe Capsules and Tablets Market, By Country
3.4.1.3 Asia-Pacific Capsules and Tablets Market, By Country
3.4.1.4 Rest of World Capsules and Tablets Market, By Country
3.5. Eye Drops
3.5.1 Eye Drops Market, By Region
3.5.1.1 North America Eye Drops Market, By Country
3.5.1.2 Europe Eye Drops Market, By Country
3.5.1.3 Asia-Pacific Eye Drops Market, By Country
3.5.1.4 Rest of World Eye Drops Market, By Country
3.6. Ointments
3.6.1 Ointments Market, By Region
3.6.1.1 North America Ointments Market, By Country
3.6.1.2 Europe Ointments Market, By Country
3.6.1.3 Asia-Pacific Ointments Market, By Country
3.6.1.4 Rest of World Ointments Market, By Country
4. Global Ophthalmology Drugs Market, By Route of Administration
4.1. Overview
4.2. Topical
4.2.1 Topical Market, By Region
4.2.1.1 North America Topical Market, By Country
4.2.1.2 Europe Topical Market, By Country
4.2.1.3 Asia-Pacific Topical Market, By Country
4.2.1.4 Rest of World Topical Market, By Country
4.3. Local Ocular
4.3.1 Local Ocular Market, By Region
4.3.1.1 North America Local Ocular Market, By Country
4.3.1.2 Europe Local Ocular Market, By Country
4.3.1.3 Asia-Pacific Local Ocular Market, By Country
4.3.1.4 Rest of World Local Ocular Market, By Country
4.4. Systemic
4.4.1 Systemic Market, By Region
4.4.1.1 North America Systemic Market, By Country
4.4.1.2 Europe Systemic Market, By Country
4.4.1.3 Asia-Pacific Systemic Market, By Country
4.4.1.4 Rest of World Systemic Market, By Country
5. Global Ophthalmology Drugs Market, By Product Type
5.1. Overview
5.2. Prescription Drugs
5.2.1 Prescription Drugs Market, By Region
5.2.1.1 North America Prescription Drugs Market, By Country
5.2.1.2 Europe Prescription Drugs Market, By Country
5.2.1.3 Asia-Pacific Prescription Drugs Market, By Country
5.2.1.4 Rest of World Prescription Drugs Market, By Country
5.3. OTC Drugs
5.3.1 OTC Drugs Market, By Region
5.3.1.1 North America OTC Drugs Market, By Country
5.3.1.2 Europe OTC Drugs Market, By Country
5.3.1.3 Asia-Pacific OTC Drugs Market, By Country
5.3.1.4 Rest of World OTC Drugs Market, By Country
6. Global Ophthalmology Drugs Market, By Region
6.1. Overview
6.2. North America
6.2.1 North America Ophthalmology Drugs Market, By Drug Class
6.2.2 North America Ophthalmology Drugs Market, By Disease
6.2.3 North America Ophthalmology Drugs Market, By Dosage Form
6.2.4 North America Ophthalmology Drugs Market, By Route of Administration
6.2.5 North America Ophthalmology Drugs Market, By Product Type
6.2.6 North America Ophthalmology Drugs Market, By Country
6.2.6.1 U.S.
6.2.6.1.1 U.S. Ophthalmology Drugs Market, By Drug Class
6.2.6.1.2 U.S. Ophthalmology Drugs Market, By Disease
6.2.6.1.3 U.S. Ophthalmology Drugs Market, By Dosage Form
6.2.6.1.4 U.S. Ophthalmology Drugs Market, By Route of Administration
6.2.6.1.5 U.S. Ophthalmology Drugs Market, By Product Type
6.2.6.2 Canada
6.2.6.2.1 Canada Ophthalmology Drugs Market, By Drug Class
6.2.6.2.2 Canada Ophthalmology Drugs Market, By Disease
6.2.6.2.3 Canada Ophthalmology Drugs Market, By Dosage Form
6.2.6.2.4 Canada Ophthalmology Drugs Market, By Route of Administration
6.2.6.2.5 Canada Ophthalmology Drugs Market, By Product Type
6.3. Europe
6.3.1 Europe Ophthalmology Drugs Market, By Drug Class
6.3.2 Europe Ophthalmology Drugs Market, By Disease
6.3.3 Europe Ophthalmology Drugs Market, By Dosage Form
6.3.4 Europe Ophthalmology Drugs Market, By Route of Administration
6.3.5 Europe Ophthalmology Drugs Market, By Product Type
6.3.6 Europe Ophthalmology Drugs Market, By Country
6.3.6.1 Germany
6.3.6.1.1 Germany Ophthalmology Drugs Market, By Drug Class
6.3.6.1.2 Germany Ophthalmology Drugs Market, By Disease
6.3.6.1.3 Germany Ophthalmology Drugs Market, By Dosage Form
6.3.6.1.4 Germany Ophthalmology Drugs Market, By Route of Administration
6.3.6.1.5 Germany Ophthalmology Drugs Market, By Product Type
6.3.6.2 U.K.
6.3.6.2.1 U.K. Ophthalmology Drugs Market, By Drug Class
6.3.6.2.2 U.K. Ophthalmology Drugs Market, By Disease
6.3.6.2.3 U.K. Ophthalmology Drugs Market, By Dosage Form
6.3.6.2.4 U.K. Ophthalmology Drugs Market, By Route of Administration
6.3.6.2.5 U.K. Ophthalmology Drugs Market, By Product Type
6.3.6.3 France
6.3.6.3.1 France Ophthalmology Drugs Market, By Drug Class
6.3.6.3.2 France Ophthalmology Drugs Market, By Disease
6.3.6.3.3 France Ophthalmology Drugs Market, By Dosage Form
6.3.6.3.4 France Ophthalmology Drugs Market, By Route of Administration
6.3.6.3.5 France Ophthalmology Drugs Market, By Product Type
6.3.6.4 Italy
6.3.6.4.1 Italy Ophthalmology Drugs Market, By Drug Class
6.3.6.4.2 Italy Ophthalmology Drugs Market, By Disease
6.3.6.4.3 Italy Ophthalmology Drugs Market, By Dosage Form
6.3.6.4.4 Italy Ophthalmology Drugs Market, By Route of Administration
6.3.6.4.5 Italy Ophthalmology Drugs Market, By Product Type
6.3.6.5 Spain
6.3.6.5.1 Spain Ophthalmology Drugs Market, By Drug Class
6.3.6.5.2 Spain Ophthalmology Drugs Market, By Disease
6.3.6.5.3 Spain Ophthalmology Drugs Market, By Dosage Form
6.3.6.5.4 Spain Ophthalmology Drugs Market, By Route of Administration
6.3.6.5.5 Spain Ophthalmology Drugs Market, By Product Type
6.3.6.6 Rest of Europe
6.3.6.6.1 Rest of Europe Ophthalmology Drugs Market, By Drug Class
6.3.6.6.2 Rest of Europe Ophthalmology Drugs Market, By Disease
6.3.6.6.3 Rest of Europe Ophthalmology Drugs Market, By Dosage Form
6.3.6.6.4 Rest of Europe Ophthalmology Drugs Market, By Route of Administration
6.3.6.6.5 Rest of Europe Ophthalmology Drugs Market, By Product Type
6.4. Asia-Pacific
6.4.1 Asia-Pacific Ophthalmology Drugs Market, By Drug Class
6.4.2 Asia-Pacific Ophthalmology Drugs Market, By Disease
6.4.3 Asia-Pacific Ophthalmology Drugs Market, By Dosage Form
6.4.4 Asia-Pacific Ophthalmology Drugs Market, By Route of Administration
6.4.5 Asia-Pacific Ophthalmology Drugs Market, By Product Type
6.4.6 Asia-Pacific Ophthalmology Drugs Market, By Country
6.4.6.1 China
6.4.6.1.1 China Ophthalmology Drugs Market, By Drug Class
6.4.6.1.2 China Ophthalmology Drugs Market, By Disease
6.4.6.1.3 China Ophthalmology Drugs Market, By Dosage Form
6.4.6.1.4 China Ophthalmology Drugs Market, By Route of Administration
6.4.6.1.5 China Ophthalmology Drugs Market, By Product Type
6.4.6.2 Japan
6.4.6.2.1 Japan Ophthalmology Drugs Market, By Drug Class
6.4.6.2.2 Japan Ophthalmology Drugs Market, By Disease
6.4.6.2.3 Japan Ophthalmology Drugs Market, By Dosage Form
6.4.6.2.4 Japan Ophthalmology Drugs Market, By Route of Administration
6.4.6.2.5 Japan Ophthalmology Drugs Market, By Product Type
6.4.6.3 South Korea
6.4.6.3.1 South Korea Ophthalmology Drugs Market, By Drug Class
6.4.6.3.2 South Korea Ophthalmology Drugs Market, By Disease
6.4.6.3.3 South Korea Ophthalmology Drugs Market, By Dosage Form
6.4.6.3.4 South Korea Ophthalmology Drugs Market, By Route of Administration
6.4.6.3.5 South Korea Ophthalmology Drugs Market, By Product Type
6.4.6.4 India
6.4.6.4.1 India Ophthalmology Drugs Market, By Drug Class
6.4.6.4.2 India Ophthalmology Drugs Market, By Disease
6.4.6.4.3 India Ophthalmology Drugs Market, By Dosage Form
6.4.6.4.4 India Ophthalmology Drugs Market, By Route of Administration
6.4.6.4.5 India Ophthalmology Drugs Market, By Product Type
6.4.6.5 Indonesia
6.4.6.5.1 Indonesia Ophthalmology Drugs Market, By Drug Class
6.4.6.5.2 Indonesia Ophthalmology Drugs Market, By Disease
6.4.6.5.3 Indonesia Ophthalmology Drugs Market, By Dosage Form
6.4.6.5.4 Indonesia Ophthalmology Drugs Market, By Route of Administration
6.4.6.5.5 Indonesia Ophthalmology Drugs Market, By Product Type
6.4.6.6 Rest of Asia
6.4.6.6.1 Rest of Asia Ophthalmology Drugs Market, By Drug Class
6.4.6.6.2 Rest of Asia Ophthalmology Drugs Market, By Disease
6.4.6.6.3 Rest of Asia Ophthalmology Drugs Market, By Dosage Form
6.4.6.6.4 Rest of Asia Ophthalmology Drugs Market, By Route of Administration
6.4.6.6.5 Rest of Asia Ophthalmology Drugs Market, By Product Type
6.5. Rest of World
6.5.1 Rest of World Ophthalmology Drugs Market, By Drug Class
6.5.2 Rest of World Ophthalmology Drugs Market, By Disease
6.5.3 Rest of World Ophthalmology Drugs Market, By Dosage Form
6.5.4 Rest of World Ophthalmology Drugs Market, By Route of Administration
6.5.5 Rest of World Ophthalmology Drugs Market, By Product Type
6.5.6 Rest of World Ophthalmology Drugs Market, By Country
6.5.6.1 Brazil
6.5.6.1.1 Brazil Ophthalmology Drugs Market, By Drug Class
6.5.6.1.2 Brazil Ophthalmology Drugs Market, By Disease
6.5.6.1.3 Brazil Ophthalmology Drugs Market, By Dosage Form
6.5.6.1.4 Brazil Ophthalmology Drugs Market, By Route of Administration
6.5.6.1.5 Brazil Ophthalmology Drugs Market, By Product Type
6.5.6.2 Mexico
6.5.6.2.1 Mexico Ophthalmology Drugs Market, By Drug Class
6.5.6.2.2 Mexico Ophthalmology Drugs Market, By Disease
6.5.6.2.3 Mexico Ophthalmology Drugs Market, By Dosage Form
6.5.6.2.4 Mexico Ophthalmology Drugs Market, By Route of Administration
6.5.6.2.5 Mexico Ophthalmology Drugs Market, By Product Type
6.5.6.3 South Africa
6.5.6.3.1 South Africa Ophthalmology Drugs Market, By Drug Class
6.5.6.3.2 South Africa Ophthalmology Drugs Market, By Disease
6.5.6.3.3 South Africa Ophthalmology Drugs Market, By Dosage Form
6.5.6.3.4 South Africa Ophthalmology Drugs Market, By Route of Administration
6.5.6.3.5 South Africa Ophthalmology Drugs Market, By Product Type
6.5.6.4 Australia
6.5.6.4.1 Australia Ophthalmology Drugs Market, By Drug Class
6.5.6.4.2 Australia Ophthalmology Drugs Market, By Disease
6.5.6.4.3 Australia Ophthalmology Drugs Market, By Dosage Form
6.5.6.4.4 Australia Ophthalmology Drugs Market, By Route of Administration
6.5.6.4.5 Australia Ophthalmology Drugs Market, By Product Type
6.5.6.5 RoW Countries
6.5.6.5.1 RoW Countries Ophthalmology Drugs Market, By Drug Class
6.5.6.5.2 RoW Countries Ophthalmology Drugs Market, By Disease
6.5.6.5.3 RoW Countries Ophthalmology Drugs Market, By Dosage Form
6.5.6.5.4 RoW Countries Ophthalmology Drugs Market, By Route of Administration
6.5.6.5.5 RoW Countries Ophthalmology Drugs Market, By Product Type
RoW Countries Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 2. Antiallergy Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Antiallergy Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Antiallergy Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Antiallergy Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Antiallergy Market Value, By Country, 2022-2031, Million USD
TABLE 7. Anti-inflammatory Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Anti-inflammatory Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Anti-inflammatory Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Anti-inflammatory Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Anti-inflammatory Market Value, By Country, 2022-2031, Million USD
TABLE 12. Anti-VEGF Agents Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Anti-VEGF Agents Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Anti-VEGF Agents Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Anti-VEGF Agents Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Anti-VEGF Agents Market Value, By Country, 2022-2031, Million USD
TABLE 17. Anti-glaucoma Market Value, By Region, 2022-2031, Million USD
TABLE 18. North America Anti-glaucoma Market Value, By Country, 2022-2031, Million USD
TABLE 19. Europe Anti-glaucoma Market Value, By Country, 2022-2031, Million USD
TABLE 20. Asia-Pacific Anti-glaucoma Market Value, By Country, 2022-2031, Million USD
TABLE 21. Rest of World Anti-glaucoma Market Value, By Country, 2022-2031, Million USD
TABLE 22. Other Drug Classes Market Value, By Region, 2022-2031, Million USD
TABLE 23. North America Other Drug Classes Market Value, By Country, 2022-2031, Million USD
TABLE 24. Europe Other Drug Classes Market Value, By Country, 2022-2031, Million USD
TABLE 25. Asia-Pacific Other Drug Classes Market Value, By Country, 2022-2031, Million USD
TABLE 26. Rest of World Other Drug Classes Market Value, By Country, 2022-2031, Million USD
TABLE 27. Global Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 28. Dry Eye Market Value, By Region, 2022-2031, Million USD
TABLE 29. North America Dry Eye Market Value, By Country, 2022-2031, Million USD
TABLE 30. Europe Dry Eye Market Value, By Country, 2022-2031, Million USD
TABLE 31. Asia-Pacific Dry Eye Market Value, By Country, 2022-2031, Million USD
TABLE 32. Rest of World Dry Eye Market Value, By Country, 2022-2031, Million USD
TABLE 33. Eye Allergy Market Value, By Region, 2022-2031, Million USD
TABLE 34. North America Eye Allergy Market Value, By Country, 2022-2031, Million USD
TABLE 35. Europe Eye Allergy Market Value, By Country, 2022-2031, Million USD
TABLE 36. Asia-Pacific Eye Allergy Market Value, By Country, 2022-2031, Million USD
TABLE 37. Rest of World Eye Allergy Market Value, By Country, 2022-2031, Million USD
TABLE 38. Glaucoma Market Value, By Region, 2022-2031, Million USD
TABLE 39. North America Glaucoma Market Value, By Country, 2022-2031, Million USD
TABLE 40. Europe Glaucoma Market Value, By Country, 2022-2031, Million USD
TABLE 41. Asia-Pacific Glaucoma Market Value, By Country, 2022-2031, Million USD
TABLE 42. Rest of World Glaucoma Market Value, By Country, 2022-2031, Million USD
TABLE 43. Eye Infection Market Value, By Region, 2022-2031, Million USD
TABLE 44. North America Eye Infection Market Value, By Country, 2022-2031, Million USD
TABLE 45. Europe Eye Infection Market Value, By Country, 2022-2031, Million USD
TABLE 46. Asia-Pacific Eye Infection Market Value, By Country, 2022-2031, Million USD
TABLE 47. Rest of World Eye Infection Market Value, By Country, 2022-2031, Million USD
TABLE 48. Retinal Disorders Market Value, By Region, 2022-2031, Million USD
TABLE 49. North America Retinal Disorders Market Value, By Country, 2022-2031, Million USD
TABLE 50. Europe Retinal Disorders Market Value, By Country, 2022-2031, Million USD
TABLE 51. Asia-Pacific Retinal Disorders Market Value, By Country, 2022-2031, Million USD
TABLE 52. Rest of World Retinal Disorders Market Value, By Country, 2022-2031, Million USD
TABLE 53. Other Diseases Market Value, By Region, 2022-2031, Million USD
TABLE 54. North America Other Diseases Market Value, By Country, 2022-2031, Million USD
TABLE 55. Europe Other Diseases Market Value, By Country, 2022-2031, Million USD
TABLE 56. Asia-Pacific Other Diseases Market Value, By Country, 2022-2031, Million USD
TABLE 57. Rest of World Other Diseases Market Value, By Country, 2022-2031, Million USD
TABLE 58. Global Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 59. Gels Market Value, By Region, 2022-2031, Million USD
TABLE 60. North America Gels Market Value, By Country, 2022-2031, Million USD
TABLE 61. Europe Gels Market Value, By Country, 2022-2031, Million USD
TABLE 62. Asia-Pacific Gels Market Value, By Country, 2022-2031, Million USD
TABLE 63. Rest of World Gels Market Value, By Country, 2022-2031, Million USD
TABLE 64. Eye Solutions & Suspensions Market Value, By Region, 2022-2031, Million USD
TABLE 65. North America Eye Solutions & Suspensions Market Value, By Country, 2022-2031, Million USD
TABLE 66. Europe Eye Solutions & Suspensions Market Value, By Country, 2022-2031, Million USD
TABLE 67. Asia-Pacific Eye Solutions & Suspensions Market Value, By Country, 2022-2031, Million USD
TABLE 68. Rest of World Eye Solutions & Suspensions Market Value, By Country, 2022-2031, Million USD
TABLE 69. Capsules and Tablets Market Value, By Region, 2022-2031, Million USD
TABLE 70. North America Capsules and Tablets Market Value, By Country, 2022-2031, Million USD
TABLE 71. Europe Capsules and Tablets Market Value, By Country, 2022-2031, Million USD
TABLE 72. Asia-Pacific Capsules and Tablets Market Value, By Country, 2022-2031, Million USD
TABLE 73. Rest of World Capsules and Tablets Market Value, By Country, 2022-2031, Million USD
TABLE 74. Eye Drops Market Value, By Region, 2022-2031, Million USD
TABLE 75. North America Eye Drops Market Value, By Country, 2022-2031, Million USD
TABLE 76. Europe Eye Drops Market Value, By Country, 2022-2031, Million USD
TABLE 77. Asia-Pacific Eye Drops Market Value, By Country, 2022-2031, Million USD
TABLE 78. Rest of World Eye Drops Market Value, By Country, 2022-2031, Million USD
TABLE 79. Ointments Market Value, By Region, 2022-2031, Million USD
TABLE 80. North America Ointments Market Value, By Country, 2022-2031, Million USD
TABLE 81. Europe Ointments Market Value, By Country, 2022-2031, Million USD
TABLE 82. Asia-Pacific Ointments Market Value, By Country, 2022-2031, Million USD
TABLE 83. Rest of World Ointments Market Value, By Country, 2022-2031, Million USD
TABLE 84. Global Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 85. Topical Market Value, By Region, 2022-2031, Million USD
TABLE 86. North America Topical Market Value, By Country, 2022-2031, Million USD
TABLE 87. Europe Topical Market Value, By Country, 2022-2031, Million USD
TABLE 88. Asia-Pacific Topical Market Value, By Country, 2022-2031, Million USD
TABLE 89. Rest of World Topical Market Value, By Country, 2022-2031, Million USD
TABLE 90. Local Ocular Market Value, By Region, 2022-2031, Million USD
TABLE 91. North America Local Ocular Market Value, By Country, 2022-2031, Million USD
TABLE 92. Europe Local Ocular Market Value, By Country, 2022-2031, Million USD
TABLE 93. Asia-Pacific Local Ocular Market Value, By Country, 2022-2031, Million USD
TABLE 94. Rest of World Local Ocular Market Value, By Country, 2022-2031, Million USD
TABLE 95. Systemic Market Value, By Region, 2022-2031, Million USD
TABLE 96. North America Systemic Market Value, By Country, 2022-2031, Million USD
TABLE 97. Europe Systemic Market Value, By Country, 2022-2031, Million USD
TABLE 98. Asia-Pacific Systemic Market Value, By Country, 2022-2031, Million USD
TABLE 99. Rest of World Systemic Market Value, By Country, 2022-2031, Million USD
TABLE 100. Global Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 101. Prescription Drugs Market Value, By Region, 2022-2031, Million USD
TABLE 102. North America Prescription Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 103. Europe Prescription Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 104. Asia-Pacific Prescription Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 105. Rest of World Prescription Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 106. OTC Drugs Market Value, By Region, 2022-2031, Million USD
TABLE 107. North America OTC Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 108. Europe OTC Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 109. Asia-Pacific OTC Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 110. Rest of World OTC Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 111. Global Ophthalmology Drugs Market Value, By Region, 2022-2031, Million USD
TABLE 112. North America Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 113. North America Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 114. North America Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 115. North America Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 116. North America Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 117. North America Ophthalmology Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 118. U.S. Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 119. U.S. Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 120. U.S. Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 121. U.S. Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 122. U.S. Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 123. Canada Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 124. Canada Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 125. Canada Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 126. Canada Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 127. Canada Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 128. Europe Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 129. Europe Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 130. Europe Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 131. Europe Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 132. Europe Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 133. Europe Ophthalmology Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 134. Germany Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 135. Germany Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 136. Germany Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 137. Germany Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 138. Germany Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 139. U.K. Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 140. U.K. Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 141. U.K. Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 142. U.K. Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 143. U.K. Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 144. France Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 145. France Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 146. France Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 147. France Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 148. France Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 149. Italy Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 150. Italy Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 151. Italy Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 152. Italy Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 153. Italy Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 154. Spain Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 155. Spain Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 156. Spain Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 157. Spain Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 158. Spain Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 159. Rest of Europe Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 160. Rest of Europe Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 161. Rest of Europe Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 162. Rest of Europe Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 163. Rest of Europe Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 164. Asia-Pacific Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 165. Asia-Pacific Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 166. Asia-Pacific Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 167. Asia-Pacific Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 168. Asia-Pacific Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD
TABLE 169. Asia-Pacific Ophthalmology Drugs Market Value, By Country, 2022-2031, Million USD
TABLE 170. China Ophthalmology Drugs Market Value, By Drug Class, 2022-2031, Million USD
TABLE 171. China Ophthalmology Drugs Market Value, By Disease, 2022-2031, Million USD
TABLE 172. China Ophthalmology Drugs Market Value, By Dosage Form, 2022-2031, Million USD
TABLE 173. China Ophthalmology Drugs Market Value, By Route of Administration, 2022-2031, Million USD
TABLE 174. China Ophthalmology Drugs Market Value, By Product Type, 2022-2031, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us